WINMED’s Women Healthcare business unit is committed to several other aspects of female healthcare. Our range of products which is constantly expanding, now includes Maternal-Fetal medicine. This comprises of Down’s syndrome and genetic screening test, pregnancy monitoring and cervical dilators.

Products from


The company imports products for cervical cancer detection and surgical gynecology from Hologic Company of the United States. Which is an outstanding company in women's health care products. All products are certified by the Food and Drug Administration, United States of America (US-FDA), which is a world-class advanced medical standard.

ThinPrep Pap Test

Benefits of the ThinPrep Pap Test include; increased screening accuracy and superior patient comfort; multiple tests can be performed using one sample specimen, which limits the need for further samples to be collected. The ThinPrep Pap Test Provides screening for human papillomavirus (HPV) making it an invaluable step in establishing all-round awareness of patient’s state of health.

For further information


To identify high-risk HPV infections by targeting E6/E7 mRNA. Studies show that targeting E6/E7 mRNA identifies the presence and activity of a high-risk HPV infection. The APT HPV ASSEY represents the next generation in cervical screening – allowing clinicians to deliver maximum benefit to patients, while minimizing potential harm.

The APT HPV ASSEY identifies patients at greatest risk of developing cervical cancer, delivering the same excellent sensitivity to minimize false negative results. The APT HPV ASSEY demonstrates the same excellent sensitivity as DNA-based HPV tests innumerous clinical studies involving over 50,000 women worldwide.

For further information


The Centers for Disease Control and Prevention (CDC) estimates that only 38% of sexually active young women are screened annually for chlamydia in the United States and that up to 75% of CT infected women are asymptomatic contributing to as many as 30% of CT infections progressing to pelvic inflammatory disease (PID) which has been shown to cause permanent damage to a woman’s reproductive system including infertility, chronic pelvic pain and ectopic pregnancy.

For further information


The fFN test presents a more reliable method of determining the likelihood of preterm birth. Administered similarly to a Pap Test, the fFN test is a safe and non-invasive method of measuring fFN levels in vaginal secretions. Usually, fFN can only be detected at the beginning of pregnancy and towards full term. Detectable levels of fFN from weeks 22 to 35 of pregnancy are a strong indicator that the patient is at high risk of delivering their baby preterm.

The fFN is valuable for its role in identifying patients who are not at risk for preterm birth. Mothers whose symptoms would otherwise be addressed with medication or lying-in can avoid disruption to their daily lives.

For further information

Products for Maternal-Fetal Medicine

The company has entered into a service agreement with SOFIVA Genomics to provide diagnostic services for various conditions of mothers and babies such as Down's syndrome and detecting abnormalities of genetic genes, etc. SOFIVA Genomics Company is a leading company from Taiwan with outstanding molecular biology genetics (Next Generation Sequencing) in Asia

The company will receive blood samples from hospital customers and sent to the laboratory of SOFIVA Genomics Company for diagnosis. When the results of the examination are received, they will be sent to the company for delivery to the hospitals that receive services.

Non Invasive Prenatal Screening: NIPS
is a service for the detection of chromosomal abnormalities in the mother's womb. It consists of abnormalities of the 21st pair of chromosomes (Down's syndrome), the 18th pair (Edward's syndrome) and the 13th pair (Patu syndrome) by puncture the maternal blood. This test can be tested from the gestational age of 10 weeks and is more than 99% accurate in detecting chromosomal abnormalities. Which this test has a lower risk of miscarriage than other tests

is a service to confirm NIPS test results in case of NIPS positive results (fetal abnormalities) by re-examination of amniotic fluid or blood biopsy.

Carrier Scan
is a service for detecting genetic disorders. In most cases, this is for family planning before having children. The test will show the result of being a carrier of hereditary diseases. Carrier Scan will reduce the risk of inherited diseases from parent to child.

Baby Check
is a service to detect carriers of various diseases by collecting blood from the heel of the newborn baby to be examined. This can be divided into 4 main disease groups:

  • Hematology group
  • Endocrine group
  • Metabolic system
  • Immune group